Consent to the Distribution of Changed Medicines Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Filgrastim 300 g/mL Injection, powder F Hoffmann-La Roche Limited, Basle, Switzerland; Parkedale Pharmaceuticals Inc., Rochester, Michigan, United States of America; and Amgen Inc., Juncos, Puerto Rico Neupogen Filgrastim 600 g/mL Injection, pre-filled syringe F Hoffmann-La Roche Limited, Basle, Switzerland; and Parkedale Pharmaceuticals Inc., Rochester, Michigan, United States of America Neupogen Dated this 7th day of April 1999. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.